Testing for SARS-CoV-2

  • Dušan Popadić Medicinski fakultet Univerzitet u Beogradu
Keywords: COVID-19, SARS-CoV-2, rtRT-PCR, antigen testing, rapid tests, t-cell response, database

Abstract


This review article describes the principles and implications of certain tests for diagnosing SARS-CoV-2 infections. The advantages and disadvantages of certain tests, both those in routine diagnostic application and those that have primarily research significance, are discussed. Also, a review of the practice of reporting results is given, as well as recommendations for its improvement.

References

1. COVID-19 CORONAVIRUS PANDEMIC [17/06/2021]. Available from: https://www.worldometers.info/coronavirus/.
2. COVID-19 Testing Overview [17/06/2021]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html.
3. Lai CC, Wang CY, Ko WC, Hsueh PR. In vitro diagnostics of coronavirus disease 2019: Technologies and application. Journal of microbiology, immunology, and infection. 2021;54(2):164-74.
4. Muruato AE, Fontes-Garfias CR, Ren P, Garcia-Blanco MA, Menachery VD, Xie X, et al. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nature communications. 2020;11(1):4059.
5. QuantiFERON SARS-CoV-2 RUO [17/06/2021]. Available from: https://www.qiagen.com/us/products/diagnostics-and-clinical-research/infectious-disease/quantiferon-sars-cov-2-ruo/?clear=true#orderinginformation.
6. Marits P, Wikström AC, Popadic D, Winqvist O, Thunberg S. Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay. Clinical immunology (Orlando, Fla). 2014;153(2):332-42.
Published
2021/10/25
Section
Review Paper